Status:

COMPLETED

Radiation Therapy in Treating Women With Localized Breast Cancer

Lead Sponsor:

Institute of Cancer Research, United Kingdom

Conditions:

Breast Cancer

Eligibility:

FEMALE

50-120 years

Phase:

NA

Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways and giving it after surgery may kill any tumor cells that remain after surgery. PU...

Detailed Description

OBJECTIVES: * Compare late normal tissue effects of standard vs 2 different dose levels of hypofractionated adjuvant whole breast radiotherapy, in terms of changes in photographic breast appearance, ...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Diagnosis of invasive carcinoma of the breast
  • Localized disease
  • Pathological tumor size \< 3.0 cm in diameter
  • Axillary node negative
  • At average or low risk of local tumor recurrence
  • Must have undergone prior breast-preserving surgery
  • No prior mastectomy
  • Complete microscopic resection of tumor
  • Hormone receptor status:
  • Not specified
  • PATIENT CHARACTERISTICS:
  • Age
  • 50 and over
  • Sex
  • Female
  • Menopausal status
  • Not specified
  • Performance status
  • Not specified
  • Life expectancy
  • Not specified
  • Hematopoietic
  • Not specified
  • Hepatic
  • Not specified
  • Renal
  • Not specified
  • Other
  • Fertile patients must use effective contraception
  • PRIOR CONCURRENT THERAPY:
  • Biologic therapy
  • Not specified
  • Chemotherapy
  • No prior neoadjuvant or adjuvant cytotoxic chemotherapy
  • Endocrine therapy
  • Not specified
  • Radiotherapy
  • No concurrent lymphatic radiotherapy
  • No concurrent radiotherapy boost to the breast
  • Surgery
  • See Disease Characteristics

Exclusion

    Key Trial Info

    Start Date :

    October 5 2004

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 9 2017

    Estimated Enrollment :

    917 Patients enrolled

    Trial Details

    Trial ID

    NCT00107497

    Start Date

    October 5 2004

    End Date

    March 9 2017

    Last Update

    February 27 2019

    Active Locations (19)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 5 (19 locations)

    1

    Sussex Cancer Centre at Royal Sussex County Hospital

    Brighton, England, United Kingdom, BN2 5BE

    2

    Cumberland Infirmary

    Carlisle, England, United Kingdom, CA2 7HY

    3

    Cheltenham General Hospital

    Cheltenham, England, United Kingdom, GL53 7AN

    4

    Royal Devon and Exeter Hospital

    Exeter, England, United Kingdom, EX2 5DW